PAION Pharma

Company snapshot

PAION Pharma GmbH is a specialized pharmaceutical company, focused on the development and distribution of life-saving medicines with innovative active ingredients. With over 20 years of pharmaceutical expertise, we are committed to making a significant contribution to improving patient care. Since February 2024, we have operated as an independent subsidiary of Humanwell Healthcare Group, strengthe

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for PAION Pharma. Not investment advice.

• What is PAION Pharma?

  PAION Pharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include refractory hypotension in distributive shock. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTria

• Is PAION Pharma publicly traded?

  PAION Pharma appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does PAION Pharma develop or market?

  We link 6 drug profile(s) where PAION Pharma is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/paion-pharma-gmbh-eu#company-drugs.

• What are the latest developments for PAION Pharma?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does PAION Pharma focus on?

  PAION Pharma focuses on refractory hypotension in distributive shock based on our analysis of their pipeline programs and drug development activities.